Latest filing published 20 Jul 2016 for Valeant Pharmaceuticals International, Inc..
No signal scores available.
Jeffrey W. Ubben appears in our data through filings on Valeant Pharmaceuticals International, Inc. shares, published by SEDI. We count 2 filings; the first trade dates from 1 October 2014 and the latest from 19 May 2015.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 20 July 2016: an option exercise, in Valeant Pharmaceuticals International, Inc. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations